Rituximab - Progress but Still Not a Final Resolution for Pemphigus Patients: Clinical Report From a Single Center Study

Overview of attention for article published in Frontiers in immunology, May 2022

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 12 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 50,070 followers.

Rituximab - Progress but Still Not a Final Resolution for Pemphigus Patients: Clinical Report From a Single Center Study: Pemphigus is a rare autoimmune disease characterized by the production of pathogenic autoantibodies, #immunology… https://t.co/TgWFMw

05 May 2022

Reply Repost Favourite

New Research: Rituximab - Progress but Still Not a Final Resolution for Pemphigus Patients: Clinical Report From a Single Center Study: Pemphigus is a rare autoimmune disease characterized by the production of pathogenic autoantibodies… https://t.co/vt1Xex

03 May 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.